CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced presentations at several upcoming investment conferences. The conference and Verastem presentation details are as follows:
14th Annual BIO CEO & Investor Conference at 2:00pm ET on Monday, February 13, 2012 at the Waldorf Astoria Hotel in New York City.
